• About Us
  • Products
  • Technology
  • Distributors
  • Investors
  • News Center
  •  
  •  

Eurobio Scientific has been listed on Euronext Growth Paris (ALERS) since 2005 and is part of the Euronext Growth BPI innovation and Next Biotech indices. It is one of the stock with the highest liquidity on Euronext Growth.

 

Navigation

  • Investors
    • Press Releases
    • Key facts and figures
    • Corporate Governance
    • Regulated Information
    • Bylaws and Certificate of incorporation
    • Financial Statements
    • Registration document
    • Shareholders Meetings
    • Financial transactions
    • Event_Center
    • Share Price
    • Analysts
    • Investor calendar
    • Investor Contact

Languages

  • English
  • Français

Print

  • CLICK HERE TO PRINT
Send this article
 


 
Home » Investors
 » Key facts and figures
Key facts and figures

 

  • Market & Segment:

   

Euronext Growth

  

 

 
  • FTSE Classification:

   

Industry: Healthcare (4000)
Sector: Pharmaceuticals and Biotechnology (4570)
Sub-sector: Biotechnology (4573)

 
 
  • ISIN Code :
  • Reuters Code:
  • Bloomberg Code:
   

FR0013240934

ALERS: FP

ALERS.PA

 
  • Initial Public Offering:

 

November 17, 2005

 
  • Share Capital 
    as of June 30, 2020:

 

€ 3,629,814.72

 
  • Number of Shares 
    as of June 30, 2020:

 

11,343,171 shares with nominal value € 0,32

Changes in Share capital (in French) 

 
  • Shareholders:

  To the company’s knowledge, the share capital of Eurobio-Scientific
on June 30, 2020 was structured as shown below :
 

 

 

Shareholders Share Capital Voting rights
Number % Nombre %
 Jean-Michel Carle Grandmougin 1,645,550 14.51 1,645,550 14.58
Denis Fortier 1,708,587 15,06 1,708,587 15,14
Other Management, supervisory board members, and Employees 84,461 0.74 84,461 0.75
Investment funds (disclosed shareholding) 296,712 2.62 296,712 2.63
Treasury Shares 55,550 0.49 0 0
Other funds and general public 7,552,311 66.58 7,552,311 66.91


Total


11,343,171


100.00


11,287,621


100.00

 

 

‹ Press Releases up Corporate Governance ›

Site map - © 2009-2020 Eurobio scientific. All Rights Reserved - Legal information -